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We have developed a method to visualize matrix-assisted laser desorption ionization imaging
mass spectrometry (MALDI IMS) data aligned with optically determinable tissue structures in
three dimensions. Details of the methodology are exemplified using the 3-D reconstruction of
myelin basic protein (MBP) in the corpus callosum of a mouse brain. In this procedure, optical
images obtained from serial coronal sections are first aligned to each other to reconstruct a
surface of the corpus callosum from segmented contours of the aligned images. The MALDI
IMS data are then coregistered to the optical images and superimposed into the surface to
create the final 3-D visualization. Correlating proteomic data with anatomical structures
provides a more comprehensive understanding of healthy and pathological brain functions,
and holds promise to be utilized in more complex anatomical arrangements. (J Am Soc Mass
Spectrom 2005, 16, 1093–1099) © 2005 American Society for Mass SpectrometryWith the introduction of computer tomography(CT, positron emission tomography (PET)and magnetic resonance imaging (MRI, 3-D
medical imaging has become important in studying
anatomical, physiological, and functional information
[1]. However, these in vivo tomographic imaging tech-
niques do not have the ability to display protein distri-
butions. Histochemical techniques provide 2-D maps of
protein distributions, but require an antibody for visu-
alizing each known protein, and only a limited number
of proteins can be visualized in each slice using this
technique. In recent years, a number of mass spectrom-
etry techniques have been used to obtain the x/y spatial
localization of many compounds on sample surfaces
[2– 6]. Of the current techniques, MALDI IMS provides
the widest m/z range of species which can be imaged
and is most commonly used to image protein distribu-
tions in thin sections of tissue. Using the technique,
imaging is accomplished by acquiring a mass spectrum
at discrete locations along a grid pattern prescribed
over the surface. The resulting data set includes the x, y
coordinates (pixel) and the corresponding spectra. By
extracting the measured intensity values for a particular
m/z plane from the data set and plotting on a color scale,
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nique to include images of serial sections from a single
specimen provides a depth dimension to the data set,
allowing the 3-D representation of even unidentified
proteins in their full spatial and multi-dimensional
distribution.
Different image modalities are often combined in
neuroimaging to assist in the understanding of brain
functions in normal and diseased stages [7–9]. Unlike in
vivo tomographic imaging techniques, 2-D modalities
such as optical, histological, and MALDI IMS images
require the specimen to be sliced into thin sections,
which can produce tissue tearing and deformation.
Therefore, correlating consecutive 2-D images to obtain
a 3-D reconstruction is more demanding. In order to
reconstruct a 3-D visualization involving data from
different modalities, the establishment of a correspon-
dence between the modalities through image registra-
tion techniques [10] is required.
The present study focuses on developing the 3-D
visualization of proteomic data correlated to anatomical
features in the brain. In the present example, we chose
to model the distribution of myelin basic protein (MBP)
in the corpus callosum (CC). The mouse brain was
chosen for our first model because of its small size and
because an atlas exists which can be used as reference
for the methodology development. To create the 3-D
model of MBP within the CC, optical, histological, and
MALDI IMS images were acquired and processed ac-
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number of registration steps were required to produce
the final 3-D protein distribution. First, optical micro-
graphs of unstained sections were aligned to a reference
atlas. Although not explicitly necessary, use of the
external reference improves the consistency of our
modeling and eliminates the step of generating our own
reference. Next, the optical images and MALDI IMS
images were registered to each other based on land-
marks visible in both imaging modalities. Finally, a 3-D
surface of the anatomical feature was created from the
aligned optical images and the created 2-D MALDI IMS
images were inserted into the 3-D surface model ac-
cording to their z coordinate position. The resulting 3-D
model provides, for the first time, a unique correlated
view of MBP distribution within the CC of mouse brain.
However, the methodology can be used to map the
distribution of any protein visible in the ion image
spatially correlated with anatomical features observed
in optical micrographs.
Methods
Specimen Preparation and Cryosectioning
The brain of a male, 6-week old C57Bl/6J mouse was
Figure 1. Steps for 3-D visualization of MALDI IMS data in a
mouse brain structure. (a) Acquisition of optical, MALDI IMS, and
histological images from serial sections. (bi) Registration of optical
images to each other using an atlas as template followed by
structure segmentation and reconstruction. (bii) Registration of
MALDI IMS image to respective optical image followed by
segmentation and insertion into reconstructed structure.removed from the skull, loosely wrapped in aluminumfoil, and immediately frozen by slow immersion into
liquid nitrogen for several seconds. The brain was
stored at 80 °C until sectioning in order to minimize
protein degradation caused by temperature and oxida-
tion [11]. The unfixed brain was sectioned at 16 °C
into successive coronal sections spanning the corpus
callosum using a cryostat (CM3050S Leica, Nussloch,
Germany). Each section was thaw-mounted onto in-
dium-tin oxide coated glass slides (Delta Technologies
Ltd., Stillwaters, MN) and stored at80 °C until time of
analysis.
Optical Image Acquisition
Prior to MALDI IMS analysis, the glass slide with the
desired mouse brain section was thawed in a vacuum
desiccator for 15 min to avoid moisture condensation
that could cause delocalization of proteins. Four black
ink dots (diameter: 800 m, printed on an adhesive
label using a laser printer, were attached to the slide
framing the brain slice for use as registration land-
marks. An optical image of the section and surrounding
landmarks was acquired using a 640  480 digital
capture board coupled to an analog camera. The image
resolution was 35 m/pixel and was stored to disk in
tiff format.
Coating Brain Section with MALDI Matrix
Paper masking was applied over the ink spots, and the
brain section was coated with MALDI matrix. The
matrix (sinapinic acid, 20 mg/ml in acetonitrile/water/
TFA 50/50/0.3, vol/vol) was deposited uniformly over
the entire mouse brain section using a TLC reagent
sprayer (Fisher Scientific, Suwanee, GA) with nitrogen
nebulizing gas. Typically 15 ml of matrix solution was
consumed by passing the spray across the section in 15
to 20 passes from a distance of approximately 15 cm.
Following each pass, the surface of the mouse brain
section was allowed to dry for up to 2 min. Humidity
and temperature were maintained at 22 °C and 50–60%
during the deposition process. The crystal layer density
was monitored between spray cycles by visual obser-
vation of the coated section under a microscope. When
a continuous layer of matrix crystals was achieved, the
coated mouse brain slice was wetted twice with 2 l of
a 0 °C cold aqueous 10 mM ammonium citrate solution
to enhance MALDI ion intensities [12].
MALDI IMS Analysis
Mass spectra were acquired on a MALDI-TOF Voyager
DE-STR mass spectrometer (Applied Biosystems, Fra-
mingham, MA) equipped with a 2Hz 337 nm nitrogen
laser. The laser spot size was 50 m as determined by
measuring ablated spots in a thin film of -CHCA
matrix. Data were acquired by averaging 150 laser shots
per spectrum using an accelerating voltage of 25 kV
under optimum delay extraction conditions. The MS
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software [13, 14] (MALDI MS Imaging Tool, MMSIT,
which interacts with the Applied Biosystems software.
Each mouse brain section and its corresponding four
ink spots were acquired in batch mode, without user
interaction. The acquired IMS images include mass
spectra only from regions of the tissue or the ink spots;
intermediate areas of the plate containing no sample
information were zero-filled to complete the rectangu-
lar image field. The resulting MALDI images were
stored in a modified form of the Analyze data format
(Mayo Foundation, Rochester, MN).
Histology
Following the MALDI IMS analysis, the mouse brain
sections were Nissl stained after MALDI matrix re-
moval. The plate with the mouse brain section was first
wetted with successive aliquots of MiliQ water and
100% ethanol before immersion into a 70% ethanol bath
for 2 min. The success of the matrix removal was
determined by microscopic inspection. The staining
procedure was previously reported [15]. Briefly, dried
sections were dehydrated in a descending series of
ethanol and water, stained using Toluidine Blue O
(0.17% Toluidine Blue O in 0.2 M acetate buffer, pH
4.45). Mouse brain sections were then washed in water,
differentiated in an ascending series of ethanol, cleared
in Histoclear (National Diagnostics, Atlanta, GA) and
coverslipped using DPX (FLUKA, Milwaukee, WI).
Optical images of the Nissl stains were acquired and
stored as described earlier.
Protein Identification
For protein identification, two male C57Bl/6J mouse
brains (0.4 g each) were homogenized and fractionated
into crude nuclear/cell membrane/cell debris pellet,
crude mitochondrial/lysosomal pellet, microsomal pel-
let, and cytosol using sequential centrifugation, as de-
scribed previously [16]. Salt extracts of the nuclear
pellet were obtained by suspending the extract first in
0.3 M NaCl/0.01M Tris-HCl (250 l; pH 7.4; 4 °C) using
a motor driven polypropylene pestle, followed by cen-
trifugation (10 min; 16,000  g; 4 °C). After removing
the supernatant, the pellet was suspended in 2 M
NaCl/5 M urea/0.01 M Tris-HCl (250 l; pH7 .5; 4 °C).
Both soluble salt extracts and the cytosolic fraction were
analyzed by MALDI mass spectrometry determining
the fraction containing the targeted proteins. This frac-
tion was then purified by reverse phase HPLC [17, 18].
HPLC fractions containing the targeted proteins were
digested with trypsin and the resulting peptides were
mass analyzed and sequenced by MS and MS-MS
analysis, using a 4700 Proteomics Analyzer (Applied
Biosystems, Foster City, CA).Image Processing
Processing of the MS image data was accomplished
using a variety of in-house and commercial software
tools. Specifically, a script was written to process each
spectrum in the image file using an 11 point Gaussian
smooth and the advanced baseline correction functions
in the Applied Biosystems Data Explorer version 4.4
application. Protein images specific to the CC were
extracted as 2-D ion density maps for each tissue
section, where the intensity of the protein was plotted
as a function of its x/y coordinates on the tissue surface.
Processing of the 2-D ion density maps was accom-
plished using Adobe Photoshop 7.0 and Matlab version
6.5 with the image toolbox (MathWorks). 3-D models
(shown in Supplementary Video 1) were rendered in
Maya from surfaces reconstructed from the segmented
and registered image features using fastRBF [19].
Results and Discussion
Data Acquisition
Accurate registration of the optical images of serial
sections requires minimal tissue tearing and deforma-
tion. Hence, a number of approaches were tested,
including variation of section thickness, and the use of
embedding media to minimize tissue tearing and de-
formation. The optimum thickness for reproducible
sectioning was 20 m; smaller sections tore easily, while
thicker sections tended to crack and warp when dehy-
drated under vacuum. To minimize tissue tearing,
several embedding media, such as OCT (optical cutting
temperature polymer), 20 – 40% gelatin solution [20],
Cryo-Gel (water based sucrose solution), or 2% (wt/
vol) carboxymethylcellulose (CMC) solution [21] were
investigated. None of the tested embedding media
produced satisfactory results due to tissue deformation,
and more importantly, contamination of subsequent
MALDI IMS analysis. Hence, optical images of 264
consecutive 20 m thick sections spanning the CC
(Bregma 3.34 to 1.94 mm) were acquired from a
nonembedded mouse brain. Ten of these sections, in
400–500 m steps throughout the tissue volume, were
subjected to MALDI IMS analysis followed by Nissl
staining to reference the sections to a stereotaxic coor-
dinate system [22].
Data Processing
Creating a 3-D visualization of proteomic data involved
two steps, inter- and intra-section registration. The
inter-section registration ensured the accurate align-
ment of optical images while the intra-section registra-
tion aligned the lower resolution MALDI IMS data to
the registered optical image of the corresponding slice.
Inter-section registration. All optical imageswere aligned
to each other in order to construct a 3-D volume of the CC.
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accuracy, including alignment based on intensity val-
ues, whole brain contours, and interior feature con-
tours. Tearing and deformation along the section
boundaries made alignment based on contour matching
and mutual intensity information unreliable. Interior
anatomical features exhibited less distortion and sec-
tions were aligned sequentially using the contour of the
CC. The contrast observed in the optical images is
relatively low because of the top-down illumination
required to observe the ink spots. Consequently, auto-
mated detection of the CC contour was not possible and
it became necessary to segment the CC by manually
defining the contour. The CC contours were segmented
from the optical images and aligned to CC contours
similarly segmented from a mouse brain atlas [23],
using a modified iterative closest point method [24] to
compute a rigid body transformation, i.e., rotation and
translation only. It should be stressed that warping or
stretching was avoided here because of the tendency to
“force fit” the images, causing unacceptable distortion
of the low contrast images. Because sections in the
reference atlas were collected at a spacing of 200 m,
each of the optical images was registered to the nearest
atlas image using distance from Bregma as reference.
Since the contour of the CC in the brain atlas exhibited
minimal variations between each 200 m interval this
was considered acceptable within the limits of our
present spatial resolution. Because the individual atlas
slices were already in registration, this technique served
to align the stack of optical images. A 3-D surface of the
segmented CC was calculated from the aligned optical
images using a surface fitting tool, FastRBF [19]. The
resulting smooth surface mesh of the CC was then
rendered using Maya [25]. For sample tissues in which
an external reference atlas doesn’t exist, an internal
reference atlas can be created by either staining alter-
nate sections from the sample tissue or successive
sections from a second tissue sample. To simplify the
methodology development, the external atlas was used
as reference. However, only a few of these exist and our
same methodology can be applied to internal references
generated by staining alternate sections of the sample
tissue or successive sections from a second tissue
sample.
Intra-section registration. 2-D MALDI IMS images were
created for proteins of interest and registered to the
corresponding optical image using landmarks visible in
both images. Ion images are of relatively low resolution,
producing anatomical boundaries which are not as
distinct as those observed in the optical data set. As a
result, we found the cumulative error produced by
aligning successive ion images to be greater than that
produced by aligning each ion image to its respective
optical image. Intrinsic landmarks, such as small holes
made through the tissue volume, were found to cause
unacceptable tearing as the nonembedded tissue was
sectioned. Artificial landmarks were created by framingthe section with black ink spots printed on adhesive
labels. The landmarks produced an intense ion image at
m/z 947 by direct laser desorption, as illustrated in the
50 m ion image shown in Figure 2a and were also
readily observed in the optical image, shown in Figure
2b. An automated algorithm (see Supplementary mate-
rial) determined the fiducials in both images and a
transformation minimizing the root mean square dis-
tance between the centroid of the fiducials was applied.
This transformation, which involves a rotation, a trans-
lation, and an isotropic scaling factor, was computed
using the methods previously described [26, 27]. Using
the relation between fiducial registration error over the
CC and registration error over the entire image [28], the
registration error of this technique was determined to
be on the order of 30 m. Since the fiducial centroids in
the IMS image were determined by irradiating the
paper surface holding the toner spots with a laser beam
from a 45° incident angle, an additional error of 60 m
was encountered. The 60 m error was caused by a
height difference of 60 m between the mouse brain
section and the paper holding the toner spots. Consid-
ering both error components, the accuracy achieved by
this technique is still less than the width of a single pixel
in the MALDI IMS images, which is 100 m. A more
detailed description of the registration algorithm along
with a discussion of the errors encountered with this
technique can be found in the Supplementary material.
The registration process as described assumes that
no shrinkage occurs during section dehydration in the
mass spectrometer. To verify this, optical images from
three serial sections ranging from 20 to 50 m thick
were collected before and after the IMS analysis. The
Figure 2. Intra-section registration. (a) Representative spectrum
from the black toner, showing intense ion atm/z 947, used to create
the IMS image. (b) The centroids of the four black ink fiducials in
the optical image are shown aligned to the corresponding fiducials
in the IMS image.corresponding optical images before and after the IMS
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information [29] based method and subtracted to high-
light surface area differences between the two corre-
sponding sections. No significant tissue shrinkage was
observed for all cases at the acquired optical image
resolution of 35 m.
Correlating anatomic structures to mass spectromet-
ric data by intra-section registration offers some practi-
cal utility as illustrated in Figure 3. In this example,
three locations were selected from an optical image of a
20 m coronal mouse brain section in the regions of
corpus callosum, cortex, and anterior commissure. The
mass spectra recorded at exactly these positions were
extracted from the MALDI IMS data to highlight pro-
teomic differences in these regions. The mass spectra
show that three ions with m/z 7065 (doubly charged),
14127 (singly charged), 18415 and 9338, are highly
expressed in the CC as well as in the anterior commis-
sure. The three primary ions were identified as MBP
(Swiss-Prot entry: P04370) isoform 8 and 5, respectively,
by purifying the brain tissue extract, followed by pro-
teolytic degradation. Three peptides from each protein
were identified by tandemmass spectrometry (MS/MS)
and protein database searching using Mascot. The ion
observed at m/z 9338 has not been identified. It is
important to note that previous IMS results [2– 4, 30 –32]
discuss protein expression in the relative context of
gross anatomical regions of the tissue sample, but with
the registration methodology described here protein
distributions can be attributed to cellular regions of the
tissue with high specificity.
A subset of the collected data set is shown in Figure
4. Five sections from the posterior to the anterior part of
the brain are shown with the corresponding optical,
histological, and MALDI IMS images of four different
ions. The tissue region was segmented from the MALDI
IMS images using the corresponding aligned optical
Figure 3. MALDI IMS analysis of a 20 m thic
The optical image of the cryosection is aligned w
the selection of specific points in the optical ima
commissure, and the extraction of the corresp
brightness in each MALDI IMS image indicates
basic protein isoform 5, (m/z 18415); myelin ba
unidentified protein, (m/z 9338).images as template. A linear intensity scale normalizedto the maximum ion intensity in the brain section was
applied to create the MALDI IMS images.
Visualization. The 3-D reconstruction of MBP isoform 5
(m/z 18415) distributed throughout the CC volume is
presented in Figure 5 and in Movie 1. The volume of the
CC, shown in yellow, was segmented from the 264
aligned optical images. Ten MALDI IMS images were
created from MBP isoform 5 using a linear color scale
ranging from yellow to green representing minimum to
maximum ion intensity. The MALDI IMS images were
segmented along the contours of the CC in the regis-
onal mouse brain section (Bregma: 1.32 mm).
s corresponding MALDI IMS data. This enables
1): corpus callosum, (2) cortex, and (3) anterior
ng mass spectra at these locations. The pixel
ntensities of the following protein ions: myelin
rotein isoform 8, (m/z 14127 and 7065); and an
Figure 4. A sub-set of the acquired images. (a) Optical images,
(b) (c) (d) MALDI IMS images corresponding to an unidentified
protein, myelin basic protein isoform 5, and myelin basic protein
isoform 8, respectively, and (e) Nissl stained images acquired from
the same mouse brain sections spanning Bregma 1.10 to 1.70.
The MALDI IMS images are aligned to the respective optical
images and segmented at the slice boundaries using the optical
image as a mask. A linear gray scale is applied to the MALDI IMS





sic pwithin the ion image.
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membrane [33], which surrounds axons in the brain.
The segmented MALDI IMS images were inserted into
the CC surface at the appropriate z-coordinate.
Object visualization addresses questions in biology
and medicine across scales, ranging from single mole-
cules to cells, organs, and finally, to whole animal and
human bodies. The main focus has primarily been to
gain anatomical, physiological, and functional informa-
tion in order to understand their relationship to each
other [34] and to detect and treat disease. The collected
information is typically retrievable in a database [35] or
atlas [23, 36]. Developing the 3-D reconstruction of
MALDI IMS data correlated to anatomical information
expands the range of current imaging applications.
Although imaging mass spectrometry does not produce
ion distribution maps for all proteins present in the
tissue, several hundred proteins can be visualized
within a sample. The developed methodology can be
used to correlate distributions of the observed proteins
with physiological and structural information observed
by in vivo imaging techniques, such as CT, PET, and
MRI. Studying the degree to which protein expression
influences structures and functions can build the bridge
between the genome and proteome. The possibility to
determine modifications of the proteins, which are not
apparent from the DNA sequence, such as isoforms and
post-translational modifications with MALDI-MS, and
to observe the localization of these modified proteins
within a tissue can enhance the understanding of their
Figure 5. 3-D visualization of MALDI IMS data. The CC volume,
shown in yellow, is reconstructed from 264 consecutive aligned
optical contours. Ten sections equally spaced throughout the CC
were analyzed by MALDI IMS and the resulting images for MBP
isoform 5 (m/z 18415) are inserted into the volume. A linear green
to yellow color scale is assigned with yellow showing no protein
signal.function.Conclusions
Correlating changes to local protein distributions
caused by diseases, such as cancer, Alzheimer’s disease,
Parkinson’s disorders, with both invasive and noninva-
sive imaging techniques, will provide a more informa-
tive and complete understanding of these diseases. The
classification of cancerous tissue based on the MALDI
MS protein profiles [37, 38] is one of the growing
diagnostic applications. Tumors are typically catego-
rized by noninvasive techniques before surgery, and
recently MRI combined with MR spectroscopy imaging
using brain metabolite information as classifier have
been developed [39]. Cross-correlating this approach
with a classification based on differentially expressed
proteins employing MALDI MS would improve the
diagnosis of tumors and even allow classification in all
three dimensions. This would also permit the visualiza-
tion of tumor heterogeneity on the proteomic level
besides commonly used histological characterization
and could lead to a more personalized treatment.
Changes in protein expression induced by a drug
candidate would also enhance the field of drug discov-
ery. The spatial localization of drugs and the resulting
changes in protein expression can give important in
vivo biological information [40]. The metabolites of
administered drugs can be analyzed simultaneously by
MALDI MS and the knowledge of their spatial localiza-
tion within the organs of the dosed animal can be useful
in the characterization of their toxicity.
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